Evidence map›Paper›PMID 30182269›Full record

ArticleLife sciences, society and policy2018

The governance structure for data access in the DIRECT consortium: an innovative medicines initiative (IMI) project.

Harriet J A Teare, Federico de Masi, Karina Banasik, Anna Barnett, Sanna Herrgard, Bernd Jablonka, Jacqueline W M Postma, Timothy J McDonald, Ian Forgie, Piotr J Chmura and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Life sciences, society and policy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Harriet J A TeareHeLEX Centre, University of Oxford, Ewert House, Banbury Road, Oxford, OX2 7DD, UK. harriet.teare@dph.ox.ac.uk.ORCID http://orcid.org/0000-0002-3783-7547
Federico de MasiCenter for Biological Sequence Analysis, Department of Bio and Health Informatics, Technical University of Denmark, Building 208, DK-2800, Lyngby, Denmark.
Karina BanasikTranslational Disease Systems Biology, NNF Center for Protein Research, University of Copenhagen, Faculty of Health and Medical Sciences, Blegdamsvej 3B, DK-2200, Copenhagen, Denmark.
Anna BarnettDivision of Molecular & Clinical Medicine, School of Medicine, University of Dundee, Ninewells Hospital & Medical School, Dundee, UK.
Sanna HerrgardCenter for Biological Sequence Analysis, Department of Bio and Health Informatics, Technical University of Denmark, Building 208, DK-2800, Lyngby, Denmark.
Bernd JablonkaSanofi-Aventis Deutschland GmbH, Industriepark Höchst, 65926, Frankfurt, Germany.
Jacqueline W M PostmaClinical Research Centre, Lund University Diabetes Centre, Box 50332, SE-202 13, Malmö, Sweden.
Timothy J McDonaldBlood Sciences, Template A2, Royal Devon and Exeter Hospital, Barrack Road, Exeter, EX2 5DW, UK.
Ian ForgieDivision of Molecular & Clinical Medicine, School of Medicine, University of Dundee, Ninewells Hospital & Medical School, Dundee, UK.
Piotr J ChmuraCenter for Biological Sequence Analysis, Department of Bio and Health Informatics, Technical University of Denmark, Building 208, DK-2800, Lyngby, Denmark.
Emil K RydzkaCenter for Biological Sequence Analysis, Department of Bio and Health Informatics, Technical University of Denmark, Building 208, DK-2800, Lyngby, Denmark.
Ramneek GuptaCenter for Biological Sequence Analysis, Department of Bio and Health Informatics, Technical University of Denmark, Building 208, DK-2800, Lyngby, Denmark.
Soren BrunakCenter for Biological Sequence Analysis, Department of Bio and Health Informatics, Technical University of Denmark, Building 208, DK-2800, Lyngby, Denmark.
Ewan PearsonDivision of Molecular & Clinical Medicine, School of Medicine, University of Dundee, Ninewells Hospital & Medical School, Dundee, UK.
Jane KayeHeLEX Centre, University of Oxford, Ewert House, Banbury Road, Oxford, OX2 7DD, UK.

Funding

Department of Health ICA-SCL-2016-02-003EU FP7 IMI JU 115317
6 · The paper itself

Abstract

Biomedical research projects involving multiple partners from public and private sectors require coherent internal governance mechanisms to engender good working relationships. The DIRECT project is an example of such a venture, funded by the Innovative Medicines Initiative Joint Undertaking (IMI JU). This paper describes the data access policy that was developed within DIRECT to support data access and sharing, via the establishment of a 3-tiered Data Access Committee. The process was intended to allow quick access to data, whilst enabling strong oversight of how data were being accessed and by whom, and any subsequent analyses, to contribute to the overall objectives of the consortium.

Indexed as

Access to InformationBiomedical ResearchClinical GovernanceDatabases, FactualPublic-Private Sector PartnershipsHumansData accessData access committeeGovernanceIMI project

Identifiers

PMID30182269
PMCPMC6123336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.